Go Pro
HC Wainwright

HC Wainwright Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

Average Return
00.00% 12-Month ROI
Total Ratings
2,072 Last 12 Months
Buy Ratings
1,901 Last 12 Months
Sell Ratings
11 Last 12 Months
Companies Covered
644 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
$6.35
-29.6%
9/28/2026Boost Price Target$27.00 ➝ $34.00BuyView details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/28/2026
Incyte Corporation stock logo
INCY
Incyte
$124.82
+0.8%
9/28/2026Boost Price Target$150.00 ➝ $152.00BuyView details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 9/28/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$89.92
+178.0%
9/28/2026Boost Price Target$58.00 ➝ $96.00BuyView details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 9/28/2026
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
$87.96
-1.9%
9/28/2026Boost Price Target$140.00 ➝ $195.00BuyView details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 9/28/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
$30.42
+4.5%
9/25/2026Reiterated Rating$27.00 ➝ $38.00BuyView details for HC Wainwright rating of Biodesix (NASDAQ:BDSX) on 9/25/2026
Cipher Mining Inc. stock logo
CIFR
Cipher Mining
$16.74
-5.6%
9/25/2026Reiterated RatingBuyView details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 9/25/2026
McDonald's Corporation stock logo
MCD
McDonald's
$233.32
-1.3%
9/25/2026 Set Price Target$250.00View details for HC Wainwright rating of McDonald’s (NYSE:MCD) on 9/25/2026
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$4.98
-2.0%
9/25/2026Reiterated RatingBuyView details for HC Wainwright rating of Coya Therapeutics (NASDAQ:COYA) on 9/25/2026
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$5.29
-2.0%
9/25/2026Reiterated RatingBuyView details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 9/25/2026
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
$6.82
+0.1%
9/25/2026Reiterated RatingBuyView details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 9/25/2026
Surrozen, Inc. stock logo
SRZN
Surrozen
$29.64
+0.3%
9/25/2026Reiterated Rating$44.00 ➝ $54.00BuyView details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 9/25/2026
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$193.89
-0.6%
9/25/2026Reiterated RatingBuyView details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 9/25/2026
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
$14.95
+0.9%
9/25/2026Boost Price Target$30.00 ➝ $35.00BuyView details for HC Wainwright rating of Cullinan Therapeutics (NASDAQ:CGEM) on 9/25/2026
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$20.53
-0.7%
9/25/2026Lower Price Target$37.00 ➝ $33.00BuyView details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 9/25/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
$4.18
+7.2%
9/25/2026Boost Price Target$5.00 ➝ $10.00BuyView details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 9/25/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$11.62
+1.5%
9/25/2026Reiterated Rating$20.00BuyView details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/25/2026
AC Immune stock logo
ACIU
AC Immune
$2.61
+3.6%
9/24/2026 Reiterated RatingBuyView details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 9/24/2026
Immunovant, Inc. stock logo
IMVT
Immunovant
$33.49
+0.6%
9/24/2026Reiterated RatingBuyView details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 9/24/2026
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
$285.65
+1.7%
9/24/2026Reiterated Rating$1,201.00BuyView details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 9/24/2026
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$45.57
+2.4%
9/24/2026Reiterated Rating$100.00BuyView details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/24/2026
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
$314.10
+4.2%
9/24/2026Reiterated Rating$358.00BuyView details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 9/24/2026
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
$26.85
+3.1%
9/24/2026Reiterated Rating$110.00BuyView details for HC Wainwright rating of Maze Therapeutics (NASDAQ:MAZE) on 9/24/2026
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
$20.81
+2.9%
9/24/2026Reiterated Rating$39.00BuyView details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 9/24/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$84.19
-0.3%
9/24/2026Reiterated Rating$120.00BuyView details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026
Americas Gold and Silver Corporation stock logo
USAS
Americas Gold and Silver
$4.50
-6.8%
9/24/2026Reiterated Rating$9.25BuyView details for HC Wainwright rating of Americas Gold and Silver (NYSEAMERICAN:USAS) on 9/24/2026
Aduro Clean Technologies Inc. stock logo
ADUR
Aduro Clean Technologies
$12.31
-2.5%
9/23/2026Reiterated Rating$22.00BuyView details for HC Wainwright rating of Aduro Clean Technologies (NASDAQ:ADUR) on 9/23/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.69
-1.2%
9/23/2026Reiterated Rating$9.00BuyView details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 9/23/2026
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$12.61
+6.1%
9/23/2026Reiterated Rating$20.00BuyView details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 9/23/2026
Palisade Bio, Inc. stock logo
PALI
Palisade Bio
$1.50
+3.4%
9/23/2026Reiterated Rating$7.00BuyView details for HC Wainwright rating of Palisade Bio (NASDAQ:PALI) on 9/23/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$15.48
-0.8%
9/23/2026Reiterated RatingNeutralView details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 9/23/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.39
+1.2%
9/23/2026Boost Price Target$11.00 ➝ $12.00BuyView details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/23/2026
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$33.03
-7.1%
9/22/2026Reiterated RatingBuyView details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 9/22/2026
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$50.80
-0.4%
9/22/2026Reiterated Rating$95.00BuyView details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 9/22/2026
Armata Pharmaceuticals, Inc. stock logo
ARMP
Armata Pharmaceuticals
$3.78
+1.1%
9/22/2026Reiterated Rating$15.00BuyView details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 9/22/2026
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
$2.79
+0.4%
9/22/2026Lower Price Target$7.00 ➝ $6.00BuyView details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 9/22/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.37
+3.7%
9/22/2026DowngradeBuy ➝ NeutralView details for HC Wainwright rating of HeartBeam (NASDAQ:BEAT) on 9/22/2026
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$31.49
+1.3%
9/22/2026Boost Price Target$42.00 ➝ $64.00BuyView details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 9/22/2026
Elemental Royalty Corp stock logo
ELE
Elemental Royalty
$19.69
-5.1%
9/22/2026Lower Price Target$33.00 ➝ $31.00BuyView details for HC Wainwright rating of Elemental Royalty (NASDAQ:ELE) on 9/22/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.52
+0.6%
9/22/2026Reiterated Rating$37.00BuyView details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 9/22/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$61.57
+3.6%
9/22/2026Reiterated Rating$67.00BuyView details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 9/22/2026
First Look: Elon’s “Starphone” (Ad)

Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel

See the full evidence behind Elon Musk's rumored new device.
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$21.45
-1.4%
9/22/2026Lower Price Target$30.00 ➝ $29.00BuyView details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 9/22/2026
Vista Gold Corp. stock logo
VGZ
Vista Gold
$2.69
-2.2%
9/22/2026Reiterated Rating$4.50BuyView details for HC Wainwright rating of Vista Gold (NYSEAMERICAN:VGZ) on 9/22/2026
Alkermes plc stock logo
ALKS
Alkermes
$40.15
-1.7%
9/21/2026 Reiterated RatingNeutralView details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 9/21/2026
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
$1.70
9/21/2026Reiterated RatingBuyView details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 9/21/2026
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$255.36
-0.2%
9/21/2026Reiterated Rating$455.00BuyView details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 9/21/2026
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
$39.79
+1.1%
9/21/2026Boost Price Target$45.00 ➝ $57.00BuyView details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 9/21/2026
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
$6.11
-3.4%
9/21/2026Reiterated Rating$18.00BuyView details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 9/21/2026
Lipocine Inc. stock logo
LPCN
Lipocine
$2.09
-0.5%
9/21/2026Reiterated Rating$4.00NeutralView details for HC Wainwright rating of Lipocine (NASDAQ:LPCN) on 9/21/2026
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
$36.72
-0.6%
9/18/2026Reiterated RatingBuyView details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 9/18/2026
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
$6.35
-29.6%
9/18/2026Reiterated Rating$27.00BuyView details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/18/2026
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$115.63
-0.4%
9/18/2026Reiterated Rating$165.00BuyView details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 9/18/2026
Oculis Holding AG stock logo
OCS
Oculis
$9.06
-2.3%
9/18/2026Boost Price Target$26.00 ➝ $39.00BuyView details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 9/18/2026
iBio, Inc. stock logo
IBIO
iBio
$1.17
-1.7%
9/17/2026Initiated Coverage$7.00BuyView details for HC Wainwright rating of iBio (NASDAQ:IBIO) on 9/17/2026
iBio, Inc. stock logo
IBIO
iBio
$1.17
-1.7%
9/17/2026Initiated Coverage$7.00BuyView details for HC Wainwright rating of iBio (NASDAQ:IBIO) on 9/17/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$89.92
+178.0%
9/17/2026Reiterated Rating$58.00BuyView details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 9/17/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
$2.93
-1.3%
9/17/2026Reiterated Rating$9.00BuyView details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 9/17/2026
AgomAb Therapeutics NV stock logo
AGMB
AgomAb Therapeutics
$10.21
-2.9%
9/16/2026Reiterated RatingBuyView details for HC Wainwright rating of AgomAb Therapeutics (NASDAQ:AGMB) on 9/16/2026
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$7.66
-20.6%
9/16/2026Reiterated Rating$25.00BuyView details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 9/16/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$49.13
+1.0%
9/15/2026Boost Price Target$65.00 ➝ $70.00BuyView details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2026
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
$1.20
-3.2%
9/15/2026UpgradeNeutral ➝ BuyView details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 9/15/2026
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$31.86
-1.4%
9/15/2026Reiterated Rating$55.00BuyView details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 9/15/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$11.62
+1.5%
9/15/2026Reiterated Rating$20.00BuyView details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/15/2026
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
$1.08
9/14/2026Reiterated Rating$7.00BuyView details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 9/14/2026
Adagene Inc. Sponsored ADR stock logo
ADAG
Adagene
$3.20
+9.2%
9/14/2026Reiterated Rating$7.00BuyView details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 9/14/2026
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
$6.92
-3.1%
9/14/2026Reiterated Rating$35.00BuyView details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 9/14/2026
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
$38.41
+6.2%
9/14/2026Reiterated Rating$70.00BuyView details for HC Wainwright rating of Definium Therapeutics (NASDAQ:DFTX) on 9/14/2026
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
$35.36
+0.1%
9/14/2026Reiterated Rating$40.00BuyView details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 9/14/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.52
+0.6%
9/14/2026Reiterated Rating$37.00BuyView details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 9/14/2026
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
$7.28
-0.1%
9/14/2026Reiterated Rating$25.00BuyView details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 9/14/2026
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
$1.19
-3.3%
9/14/2026Boost Price Target$5.00 ➝ $6.00BuyView details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 9/14/2026
Centene Corporation stock logo
CNC
Centene
$62.45
+1.0%
9/11/2026 Reiterated RatingBuyView details for HC Wainwright rating of Centene (NYSE:CNC) on 9/11/2026
Dakota Gold Corp. stock logo
DC
Dakota Gold
$6.18
-6.5%
9/11/2026Reiterated RatingBuyView details for HC Wainwright rating of Dakota Gold (NYSE:DC) on 9/11/2026
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
$9.74
-1.1%
9/11/2026Reiterated RatingBuyView details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 9/11/2026
MARA Holdings stock logo
MARA
MARA
$12.11
-3.5%
9/11/2026Initiated Coverage$20.00BuyView details for HC Wainwright rating of MARA (NASDAQ:MARA) on 9/11/2026
Ovid Therapeutics stock logo
OVID
Ovid Therapeutics
$2.46
+2.5%
9/11/2026Boost Price Target$4.00 ➝ $5.00BuyView details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 9/11/2026
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$8.63
+3.1%
9/11/2026Reiterated Rating$20.00BuyView details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
$85.08
+0.1%
9/11/2026Boost Price Target$56.00 ➝ $66.00BuyView details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 9/11/2026
Verastem, Inc. stock logo
VSTM
Verastem
$7.77
+0.4%
9/11/2026Reiterated Rating$18.00BuyView details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 9/11/2026
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$64.92
-0.5%
9/10/2026Reiterated Rating$120.00BuyView details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 9/10/2026
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$230.05
+2.0%
9/10/2026Set Price Target$344.00View details for HC Wainwright rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/10/2026
Atlas Lithium Corporation stock logo
ATLX
Atlas Lithium
$2.52
-6.7%
9/10/2026Lower Price Target$12.50 ➝ $11.50BuyView details for HC Wainwright rating of Atlas Lithium (NASDAQ:ATLX) on 9/10/2026
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$66.61
+1.6%
9/10/2026Reiterated Rating$120.00BuyView details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 9/10/2026
Biohaven Ltd. stock logo
BHVN
Biohaven
$13.28
+2.2%
9/10/2026Reiterated Rating$10.00NeutralView details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 9/10/2026
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$59.46
-1.3%
9/10/2026Reiterated Rating$60.00NeutralView details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 9/10/2026
Immunome, Inc. stock logo
IMNM
Immunome
$21.68
+1.3%
9/10/2026Reiterated Rating$40.00BuyView details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 9/10/2026
Immunic, Inc. stock logo
IMUX
Immunic
$9.51
+1.7%
9/10/2026Reiterated Rating$22.00BuyView details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 9/10/2026
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$2.90
+1.4%
9/10/2026Boost Price Target$7.00 ➝ $8.00BuyView details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 9/10/2026
Seaport Therapeutics, Inc. stock logo
SPTX
Seaport Therapeutics
$19.64
-8.7%
9/10/2026Reiterated Rating$50.00BuyView details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 9/10/2026
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$21.45
-1.4%
9/10/2026Lower Price Target$45.00 ➝ $30.00BuyView details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
$35.06
-2.4%
9/9/2026Reiterated RatingBuyView details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 9/9/2026
Trump goes "all-in" on Grand Canyon energy breakthrough (Ad)

A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel

See the ticker behind this Grand Canyon energy breakthrough now
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.39
+1.2%
9/9/2026Initiated Coverage$11.00BuyView details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/9/2026
Emergent Biosolutions Inc. stock logo
EBS
Emergent Biosolutions
$6.86
+1.0%
9/9/2026Reiterated Rating$10.00BuyView details for HC Wainwright rating of Emergent Biosolutions (NYSE:EBS) on 9/9/2026
Evommune, Inc. stock logo
EVMN
Evommune
$8.38
-1.4%
9/9/2026Reiterated RatingNeutralView details for HC Wainwright rating of Evommune (NYSE:EVMN) on 9/9/2026
Adherex Technologies Inc. stock logo
FENC
Adherex Technologies
$10.95
+3.3%
9/9/2026Reiterated Rating$16.00BuyView details for HC Wainwright rating of Adherex Technologies (NASDAQ:FENC) on 9/9/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$5.05
+6.1%
9/9/2026Reiterated Rating$8.00BuyView details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$11.42
-2.8%
9/9/2026Reiterated Rating$25.00BuyView details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 9/9/2026
PepGen, Inc. stock logo
PEPG
PepGen
$2.59
9/9/2026Reiterated RatingBuyView details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 9/9/2026
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$2.69
-1.1%
9/9/2026Reiterated Rating$12.00BuyView details for HC Wainwright rating of Protalix BioTherapeutics (NYSE:PLX) on 9/9/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.39
+1.2%
9/9/2026Initiated Coverage$11.00BuyView details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/9/2026
U.S. GoldMining Inc. stock logo
USGO
U.S. GoldMining
$6.92
-3.8%
9/9/2026Reiterated Rating$30.75BuyView details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 9/9/2026

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

HC Wainwright's equity research team has issued ratings on 641 companies across 11 sectors over the past 12 months, covered by 28 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Healthcare (73.1%), Technology (8.5%) and Materials (6.1%). The chart below shows how HC Wainwright's 644 rated companies are distributed across all 11 sectors it covers.

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 601 companies. Recent upgrades to buy include Cardiff Oncology, Alumis and Prime Medicine.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Robert Burns, Andrew Fein and Patrick R. Trucchio. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 28 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Healthcare (73.1% of rated companies), Technology (8.5% of rated companies), Materials (6.1% of rated companies), Industrials (5.3% of rated companies) and Finance (2.3% of rated companies).

HC Wainwright issued 2,072 ratings over the last 12 months across 644 companies — an average of roughly 173 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.